Home
About
Pricing
Log In
Back
PCKN

This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.

Asset Logo

Painchek Ltd

πŸ‡¦πŸ‡Ί ASX

πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸƒ Esg

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

N/A
Annual Growth

5 years average annual capital growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

3
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Painchek Ltd - Ordinary Fully Paid Deferred

πŸ“ˆ Performance

Price History

N/A

1M

All Time

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in PCKN

0

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

N/A

πŸ’΅ Average investment amount

N/A

⏰ Last time a customer invested in PCKN

N/A
PCKN investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

πŸ‘Ά Age of investors

18 - 25

26 - 34

35 - 90

πŸ™‹ Legal gender of investors

Female

Male

Pearlers who invest in PCKN also invest in...

Buxton Resources Limited

BUX

Buxton Resources Ltd. engages in the business of mineral exploration. The company is focused on the discovery and development of metalliferous ore deposits, including nickel, copper, gold, iron, and graphite. Its projects include Graphite Bull Project (BUX 100%), West Kimberley Project (three separate Joint Ventures with IGO - BUX 16% - 20%), Fraser Range Project (BUX 10%/IGO 90%), Narryer Project (BUX 100%), Copper Wolf Project (BUX 49%/IGO earning 51% on certain tenements), Centurion Project (BUX 100%), Shogun & Royale Projects (BUX 100%), Lateron Project (BUX 100%), and Madman Project (BUX 100%). The Graphite Bull Project is located 280 km East of Carnarvon in the Murchison Region of Western Australia. The West Kimberley Project is targeting Nova-style magmatic Ni-Cu sulphide mineralization in Proterozoic belts of the West Kimberley Region of Western Australia. The Narryer Project is targeting magmatic Ni-Cu-PGE sulphide mineralization along the Yilgarn Craton margin within the Murchison Region of WA.

πŸ™Œ Performance (5Yr p.a)

-15.22%

πŸ“Š Share price

$0.03 AUD

⛏️ MINING

Find Out More

πŸ“Š Share price

$0.03 AUD

Mogul Games Group Ltd. engages in the business of design and development of its online media platform. The company is headquartered in Melbourne, Victoria and currently employs 3 full-time employees. The company went IPO on 2011-10-19. The principal activities of the Company consists of gaming, esports media and software business. The firm owns and operates mogul.gg tournament platform, which is a an online esports tournament and matchmaking platform with automation for esports titles. The firm operates in two segments: eSports and Unallocated. The eSports segment consists of equity investments and intangible assets and all expenses related to the eSports business. The Unallocated segment consists of corporate, including treasury, corporate, and regulatory expenses arising from operating an entity. The firm's subsidiaries include eSports Nominees Pty Ltd, SEA Esports Pte Ltd, and GameGeek Pte Ltd.

πŸ“Š Share price

$0.03 AUD

Trigg Minerals Ltd. engages in the exploration and development of brine-hosted fertiliser minerals that are critical for the production of high-nutrient food sources. Its projects include Antimony Canyon; Achilles Antimony; Taylors Arm North Antimony; Taylors Arm South Antimony; Nundle Antimony-Gold; Spartan Antimony; Upper Hunter Antimony-Gold; Copeland & Cobark Gold-Antimony, and Drummond Epithermal & IRGS. Its flagship Antimony Canyon Project in Garfield County, Utah, holds approximately 49 unpatented lode mining claims and 20 patented mining claims. The Achilles Antimony project is an advanced-stage exploration/near-term development antimony project, which is located within Coffs Harbour Block of the New England Orogen. The Taylors Arm North Antimony Project is a high-grade, underexplored asset in the New England Orogen of northern New South Wales. The Drummond Project includes approximately 893 square kilometers across nine tenements in North Queensland’s prolific Drummond Basin, a Tier-one gold province.

πŸ™Œ Performance (5Yr p.a)

-9.03%

πŸ“Š Share price

$0.10 AUD

πŸ§ͺ CHEMICALS

Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. The company is headquartered in Perth, Western Australia. The Company’s lead product is Sofdra (sofpironium) topical gel, 12.45%, a prescription anticholinergic medicine used on the skin (topical), to treat excessive underarm sweating (primary axillary hyperhidrosis) in adults and children nine years of age and older. Sofdra regulates sweating at the site of application, by binding to the primary sweat receptor and thereby blocking the sweat signal. Its product pipeline targets the various skin diseases, such as BTX 1503 for Acne, BTX 1702 for Rosacea, BTX 1204A for Atopic Dermatitis, and BTX 1801 for Hemodialysis Patients. Its BTX 1503 is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. BTX 1702 is used for the treatment of papulopustular rosacea. BTX 1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus (MRSA).

πŸ™Œ Performance (5Yr p.a)

40.42%

πŸ“Š Share price

$0.14 AUD

πŸ“¦ LOGISTICS

πŸ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...